We are live on ! Find out more
ECM

EagleClaw Capital Management Portfolio holdings

AUM $714M
1-Year Est. Return 24.24%
This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+24.24%
3 Year Est. Return
+96.54%
5 Year Est. Return
+138.84%
10 Year Est. Return
+573.51%
AUM
$387M
AUM Growth
+$38.7M
Cap. Flow
+$12.8M
Cap. Flow %
3.32%
Top 10 Hldgs %
35.68%
Holding
140
New
12
Increased
56
Reduced
42
Closed
5

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$1.24M
2
HD icon
Home Depot
HD
+$1.03M
3
PYPL icon
PayPal
PYPL
+$1.02M
4
FMC icon
FMC
FMC
+$819K
5
RTX icon
RTX Corp
RTX
+$629K

Sector Composition

Rank Sector Weight
1 Technology 17.86%
2 Consumer Discretionary 16.85%
3 Financials 14.64%
4 Industrials 13.11%
5 Healthcare 11.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKNG icon
26
Booking.com
BKNG
$149B
$4.97M 1.29%
56,800
+4,050
+8% +$378K
LMT icon
27
Lockheed Martin
LMT
$134B
$4.27M 1.1%
11,275
+1,750
+18% +$673K
BMY icon
28
Bristol-Myers Squibb
BMY
$133B
$4.19M 1.08%
62,647
+3,800
+6% +$248K
ORCL icon
29
Oracle
ORCL
$374B
$4.08M 1.05%
52,387
+6,925
+15% +$542K
CVX icon
30
Chevron
CVX
$392B
$3.98M 1.03%
38,016
+5,175
+16% +$546K
SBUX icon
31
Starbucks
SBUX
$120B
$3.81M 0.99%
34,065
+100
+0.3% +$11.3K
BAC icon
32
Bank of America
BAC
$435B
$3.79M 0.98%
91,952
+7,200
+8% +$295K
BRK.B icon
33
Berkshire Hathaway Class B
BRK.B
$1.1T
$3.67M 0.95%
13,222
-350
-3% -$97.8K
TMO icon
34
Thermo Fisher Scientific
TMO
$213B
$3.65M 0.94%
7,240
-73
-1% -$34.4K
INTC icon
35
Intel
INTC
$455B
$3.61M 0.93%
64,331
-900
-1% -$52.8K
TJX icon
36
TJX Companies
TJX
$174B
$3.55M 0.92%
+52,650
New +$3.59M
NVO
37
Novo Nordisk
NVO
$208B
$3.16M 0.82%
75,500
+1,950
+3% +$75.6K
CAT icon
38
Caterpillar
CAT
$375B
$3.12M 0.81%
14,325
+1,650
+13% +$381K
HON icon
39
Honeywell
HON
$77B
$3.02M 0.78%
14,590
+80
+0.6% +$16.9K
WM icon
40
Waste Management
WM
$90.6B
$3M 0.78%
21,446
+5,150
+32% +$712K
CI icon
41
Cigna
CI
$73.7B
$2.93M 0.76%
12,373
+48
+0.4% +$12K
GOOGL icon
42
Alphabet (Google) Class A
GOOGL
$4.36T
$2.92M 0.76%
23,920
-3,100
-11% -$362K
GILD icon
43
Gilead Sciences
GILD
$162B
$2.92M 0.75%
42,354
+1,092
+3% +$72.9K
IBM icon
44
IBM
IBM
$211B
$2.83M 0.73%
20,209
+1,177
+6% +$161K
JNJ icon
45
Johnson & Johnson
JNJ
$618B
$2.83M 0.73%
17,179
+1,810
+12% +$300K
PCH
46
DELISTED
PotlatchDeltic
PCH
$2.76M 0.71%
52,000
+4,400
+9% +$254K
MRK icon
47
Merck
MRK
$322B
$2.57M 0.66%
33,037
+327
+1% +$24.3K
HOLX
48
DELISTED
Hologic
HOLX
$2.57M 0.66%
38,475
+300
+0.8% +$20.1K
GEN icon
49
Gen Digital
GEN
$16.4B
$2.53M 0.65%
93,000
+5,100
+6% +$127K
CL icon
50
Colgate-Palmolive
CL
$73.1B
$2.48M 0.64%
30,494
+133
+0.4% +$10.9K

Similar funds

EagleClaw Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, EagleClaw Capital Management held 140 positions worth $387M, up 11% from $348M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

EagleClaw Capital Management deployed $12.8M of net new capital in Q2 2021, opening 12 new positions and adding to 56 existing holdings. Its largest new stake was TJX Companies: 52,650 shares worth $3.55M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Amazon, an estimated $1.24M trimmed.

  • EagleClaw Capital Management's largest Q2 2021 buy was TJX Companies: 52,650 shares worth $3.55M.
  • EagleClaw Capital Management added most to Franco-Nevada in Q2 2021, an estimated $748K increase.
  • EagleClaw Capital Management's biggest Q2 2021 reduction was Amazon, cutting an estimated $1.24M.
  • EagleClaw Capital Management fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q2 2021, selling an estimated $262K.
  • EagleClaw Capital Management's ten largest holdings make up 36% of its $387M portfolio in Q2 2021.
  • EagleClaw Capital Management opened 12 new positions and closed 5 in Q2 2021.
  • EagleClaw Capital Management's portfolio value rose 11% quarter-over-quarter to $387M.

Based on EagleClaw Capital Management's 13F filing for Q2 2021, filed 10 Aug 2021.